** ResMed's Australia-listed shares RMD.AX RMD.N rise as much as 3.9% to a record high of A$44.120
** Stock posts its biggest intraday pct gain since May 21
** Medical device maker posts fourth-quarter profit ahead of Wall Street estimates
** Says profit driven by strong demand for its devices used to manage sleep apnea
** Co posts adjusted profit of $2.55 per share for the quarter ended June 30, compared with estimates of $2.48 per share
** Stock up nearly 3% this week, on track for a third consecutive week of gains
** Stock up 19.2% this year, including the day's move
(Reporting by Rajasik Mukherjee in Bengaluru)
((Rajasik.Mukherjee@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。